THORN RUN PARTNERS for NOVARTIS CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.3618, Orphan Drug Fairness Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016; issues related to the Orphan Drug Tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| WILLIAM CHRISTOPHER LAMOND | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| RICHARD CHARLES WHITE | — |
Medicare/Medicaid MMM
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| WILLIAM CHRISTOPHER LAMOND | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| RICHARD CHARLES WHITE | — |
Health Issues HCR
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015/H.R.5182, Promoting Life-Saving New Therapies for Neonates Act of 2016; neonatal drug issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| WILLIAM CHRISTOPHER LAMOND | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| RICHARD CHARLES WHITE | — |
Medical/Disease Research/Clinical Labs MED
Issues related to biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| WILLIAM CHRISTOPHER LAMOND | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| RICHARD CHARLES WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.